OR WAIT null SECS
February 07, 2019
Researchers used magnesium particles as tiny motors to deliver an oral vaccine against the bacterial pathogen Staphylococcus aureus.
February 06, 2019
The agency recommended six medicines for approval at its January 2019 meeting, including treatments for lung cancer, HIV-1, and autoimmune disorders.
The US Pharmacopeial Convention’s new plan will include new and revised quality standards and activities to support the development of new generic drugs.
February 02, 2019
Using a QbD approach in the development and formulation of topical products will enable the drug developer to provide a robust control strategy for manufacturing.
New platform technologies, advanced modeling tools, and addressing patient needs are important developments.
The challenge of achieving sustained delivery of an active ingredient or nutrient can be achieved with extended-release formulations.
Biosimilars, pricing strategies, and technology will influence growth in spending on drugs.
The market for biosimilars in Europe remains consistently robust, with 16 new biosimilars approved in 2018.
Novel analytical methods may help biologics manufacturers respond to stricter regulations on particulate matter.
February 01, 2019
Pharmapack Europe event organizers have released a report titled, ‘European drug delivery and packaging’ that forecasts an increase in innovation from smaller European companies.